Phocas Financial’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
Other funds holding PTGX
Phocas Financial's PTGX Position: Q3 2026 in Review
Phocas Financial sold out of Protagonist Therapeutics (PTGX) in Q3 2026, closing a stake of 16,378 shares — an estimated $2.01M sold.
Phocas Financial first reported a position in PTGX in Q2 2026 and held it in 1 quarter. The position peaked at $2.01M in Q2 2026. 379 funds tracked by Wall St. Rank hold PTGX as of Q3 2026.
- Phocas Financial reported no remaining Protagonist Therapeutics position as of Q3 2026 after selling out during the quarter.
- Phocas Financial sold 16,378 Protagonist Therapeutics shares in Q3 2026, an estimated $2.01M.
- Phocas Financial first reported a position in Protagonist Therapeutics in Q2 2026 and held it in 1 quarter.
- Phocas Financial's Protagonist Therapeutics position peaked at $2.01M in Q2 2026.
- 379 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q3 2026.
Based on Phocas Financial's 13F filing for Q3 2026.